Portfolio Design Labs LLC Invests $324,000 in Chemed Co. (NYSE:CHE)

Portfolio Design Labs LLC acquired a new position in shares of Chemed Co. (NYSE:CHE) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 612 shares of the company’s stock, valued at approximately $324,000.

A number of other hedge funds have also recently made changes to their positions in CHE. International Assets Investment Management LLC purchased a new position in shares of Chemed during the 3rd quarter worth approximately $437,150,000. FMR LLC boosted its position in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after purchasing an additional 45,917 shares during the period. Thrivent Financial for Lutherans boosted its position in shares of Chemed by 25.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company’s stock worth $87,752,000 after purchasing an additional 29,445 shares during the period. Aureus Asset Management LLC boosted its position in shares of Chemed by 3,147.2% during the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company’s stock worth $17,993,000 after purchasing an additional 29,017 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its position in shares of Chemed by 143.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 42,267 shares of the company’s stock worth $25,401,000 after purchasing an additional 24,912 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada lowered their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Insider Buying and Selling at Chemed

In other news, VP Brian C. Judkins acquired 145 shares of the firm’s stock in a transaction dated Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Down 0.8 %

Shares of CHE stock opened at $549.51 on Thursday. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62. The stock has a market capitalization of $8.27 billion, a PE ratio of 27.77, a P/E/G ratio of 2.16 and a beta of 0.48. The firm has a 50 day moving average of $542.24 and a two-hundred day moving average of $564.74.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.